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Molecular epidemiologic studies of strains of
Mycobacterium tuberculosis are currently conducted world-
wide. The genetically distinct Beijing family of strains has
been associated with large outbreaks of tuberculosis,
increased virulence, and multidrug resistance. However, in
this first population-based search for Beijing strains in the
Danish DNAfingerprint database, analysis of 97% of all cul-
ture-positive tuberculosis patients in 1992 to 2001 showed
that 2.5% of 3,844 patients, 1.0% of Danish-born patients,
and 3.6% of immigrants (from 85 countries) had Beijing
strains. No Beijing strains were found among 201 strains
from Danish-born patients sampled in the 1960s, and no
evidence of an increase in Beijing strains was found over
time. The true prevalence of Beijing strains worldwide is
unknown because only a fraction of global strains have
been analyzed.
N
ew technologies have enabled researchers to clarify
fundamental questions about the epidemiology and
pathogenesis of tuberculosis that were previously obscure
(1). Although the Mycobacterium tuberculosis genome is
genetically highly conserved, insertion sequences, repeti-
tive elements, genomic deletions, and single nucleotide
polymorphisms cause genetic polymorphisms. These poly-
morphisms can be visualized by various genotyping tech-
niques, often referred to as DNA fingerprinting, whereby
specific strains of M. tuberculosis can be characterized on
the basis of their DNA patterns (2). Restriction fragment
length polymorphism (RFLP) typing by using the insertion
sequence IS6110 as a probe for strain differentiation is the
most widely applied DNA fingerprinting method to study
the epidemiology of tuberculosis (1). This technique has
been used for population-based transmission surveillance
(1), including studies across national boundaries (3). In
connection with this effort, one genetically highly con-
served group of strains of M. tuberculosis collectively
known as “the Beijing family” has attracted special atten-
tion (2,4). These strains are reported to be highly prevalent
throughout Asia and in the countries of the former Soviet
Union (5–9); they may possess selective advantages com-
pared with strains of other M. tuberculosis genotypes (5);
and they are sometimes associated with multidrug resist-
ance (6,8,10,11) and with specific pathogenic properties
and increased virulence (6,8,12). Furthermore, Beijing
family strains may be increasing in frequency and be
spreading to new geographic areas (5,10,11,13). The “W-
strain family” concurrently identified on the North
American (10) and Asian continents (5) is part of the
Beijing family. In this study we investigated the Beijing
strain family in Denmark.
Methods
Data Collection
Microbiologic analyses of mycobacteria have been car-
ried out at the International Reference Laboratory of
Mycobacteriology at Statens Serum Institut in Copenhagen
since 1922. This is the only laboratory that performs cul-
ture-based tuberculosis diagnosis for the Danish Kingdom.
Since 1992, DNAfingerprinting of strains of the M. tuber-
culosis complex has been implemented on a nationwide
scale by using the internationally standardized method of
IS6110  RFLP typing (14). Fingerprints from a total of
4,102 strains from 3,844 patients were available for the
current study, representing 97% of culture-positive
patients in Denmark in 1992 to 2001. When more than one
strain was available, the earliest specimen was included in
the analysis. In addition, a search for Beijing family strains
was performed among 201 strains of M. tuberculosis
retrieved from tuberculosis patients from 1961 to 1967
(15). These strains were retrieved from Danish-born
patients who were suspected of being part of various
chains of local transmission. Ninety-five came from case-
patients living in Copenhagen, the capital city, and its sur-
roundings, where most new tuberculosis cases were, and
still are, found. The strains were freeze-dried in the 1960s
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Identification of Beijing Strains
Within the framework of the current European Union
Concerted Action project (CA project), “New Generation
Genetic Markers and Techniques for the Epidemiology
and Control of Tuberculosis,” a method of identifying the
Beijing family of strains by using IS6110 RFLP typing
was defined, on the basis of comparison with 19 reference
strains (https://hypocrates.rivm.nl/bnwww/index.html)
(K. Kremer et al., unpub. data). Following the CA project
suggested methodology, strains of M. tuberculosis with
IS6110 patterns with >80% similarity to any of these
strains could be classified as Beijing family strains,
whereas strains showing 75% to 80% similarity needed to
be confirmed by spoligotyping. This procedure should
give a sensitivity of >98% and specificity of 100% for rec-
ognizing Beijing family strains (compared with the stan-
dard criterion of spoligotyping) (K. Kremer et al., unpub.
data). For this study, for all strains showing at least 75%
similarity to any of the reference strains, spoligotyping
was used to confirm that they were indeed Beijing strains.
For statistical analysis, the p values were calculated by the
chi-square test or Fisher exact test when expected values
were small.
Results
Among the strains from the 1960s, no Beijing family
strains were identified. The results from the more recent
patients are summarized in Table 1. In total, 96 Beijing
strains were retrieved from different patients. The spoligo
patterns of 95 of these strains had 9 spacers and 1 strain
(from a patient from Vietnam) had 7 spacers of the spacers
35 to 43. Overall, 56% of the tuberculosis patients were
born outside of Denmark, originating from 85 different
countries. Among Danish-born patients, 1.0% had Beijing
strains compared to 3.6% among foreign-born patients
(Table 1). The highest prevalence of Beijing strains was
among patients from Asia. By country of origin the preva-
lence of the Beijing strain varied: 25.0% (24/96) from
Vietnam, 33.3% (12/36) from Thailand, 0% (0/44) from
the Philippines, 9.7% (3/31) from India, 8.8% (3/34) from
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Table 1. Proportion of  tuberculosis patients with Beijing family strains
a 
  Denmark-born  Non–Denmark-born  Total 
  N/N (%)  N/N (%)  N/N (%) 
All  17/1,659 (1.0)  79/2,183 (3.6)  96/3,844 (2.5) 
Male  9/1,057 (0.85)  49/1,163 (4.2)  58/2,220 (2.6) 
Female  8/602 (1.3)  30/1018 (3.0)  38/1,620 (2.4) 
Age group (y)       
< 25  2/118 (1.7)  21/655 (3.2)  23/773 (3.0) 
25–44  7/553 (1.3)  48/1,159 (4.1)  55/1,712 (3.2) 
45–64  4/522 (0.77)  6/247 (2.4)  10/769 (1.3) 
65+  4/466 (0.86)  4/121 (3.3)  8/587 (1.4) 
Y       
1992–93  4/335 (1.2)  12/249 (4.8)  16/584 (2.7) 
1994–95  2/371 (0.54)  19/418 (4.6)  21/789 (2.7) 
1996–97  2/330 (0.61)  16/506 (3.2)  18/836 (2.2) 
1998–99  4/316 (1.3)  15/555 (2.7)  19/871 (2.2) 
2000–01  5/307 (1.6)  17/455 (3.7)  22/764 (2.9) 
Area of origin       
Western Europe  17/1,659 (1.0)  0/71 (0.0)  17/1,730 (0.98) 
Eastern Europe    0/174 (0.0)   
Indian subcontinent    8/290 (2.8)   
South East Asia    37/183 (20.2)   
East Asia and Pacific    3/10 (30.0)   
Middle East    6/211 (2.8)   
North Africa    1/38 (2.6)   
Sub–Saharan Africa    20/1,111 (1.8)   
Americas and Caribbean    0/16 (0.0)   
Previous TB       
No  17/1550 (1.1)  78/2164 (3.6)  95/3,716 (2.6) 
Yes  0/109 (0.0)  1/19 (5.3)  1/128 (0.79) 
Site of TB       
Pulmonary  16/1,394 (1.2)  56/1248 (4.5)  72/2,642 (2.7) 
Extrapulmonary  1/263 (0.38)  23/930 (2.2)  24/1,193 (2.0) 
aInformation on immigration status missing for three patients; on region of origin for 81; on age for 3; on sex for 4; and on site of tuberculosis (TB) for 9. Sri Lanka, and 0% (0/220) from Pakistan. Beijing strains
were also found in 1.7% of patients from Somalia (17/985)
and in patients from the Middle East, including 7.5%
(3/40) from Iraq, 10.5% (2/19) from Iran, and 3.9% (1/ 26)
from Afghanistan. No Beijing strains were found in
patients from Eastern Europe: most of these patients (149)
were from the former Yugoslavia; 6 were from the former
Soviet Union.
No evidence was noted of an increase in the prevalence
of Beijing strains over time. Although no Beijing strains
were found in the 1960s, this finding is not significantly
different from the prevalence among Danish patients in the
recent period (p = 0.2). No increase occurred over the period
of the current study from 1992 to 2001 among Danish
patients or those born outside of Denmark (Table 1). An
apparent trend towards an increased proportion of Beijing
strains in younger patients seen overall (Table 1) is attrib-
utable to the higher proportion of immigrants in younger
age groups. Only one of the patients with the Beijing strain
had known previous tuberculosis (a patient from Somalia).
Beijing strains were less common in those without pul-
monary involvement (p = 0.007, adjusted for immigra-
tion). HIV status was not available for these patients.
The results of drug resistance testing are shown in
Table 2. Among Danish patients, but not among immi-
grants, the infections of those who had Beijing strains were
more likely to be drug resistant. The results, after exclud-
ing those with known previous tuberculosis, were very
similar (not shown). Although some of these associations
were formally statistically significant, they are based on
only two drug-resistant cases among 16 Danish-born
patients with Beijing strains. 
Discussion
This population-based study found a low prevalence of
Beijing strains and weak evidence of an association with
drug resistance. The study includes an estimated 8% of all
strains of M. tuberculosis IS6110 RFLP typed worldwide
from 1992 through 2001, of which 57% were retrieved
from foreign-born patients from 85 different countries.
Overall, only 2.5% of the patients had Beijing strains, and
no evidence was found of an increase in their prevalence
over time, even though Beijing strains have been found in
Denmark for at least 10 years.
Recently, two studies analyzed the significance of M.
tuberculosis transmission in Denmark due to immigration
from a high incidence country and the persistent high inci-
dence of tuberculosis among the immigrants in the years
after arrival (3,18). These studies concluded that most
(>75%) were infected before their arrival, that their latent
infection was reactivated, and that nearly all of those who
could have been infected after arrival (<23%) were most
likely infected by a source from the country of origin (3).
Therefore, in the present study we compared the observed
prevalence with the prevalence in the country of origin.
For example, 25% of patients from Vietnam had Beijing
strains compared with 54% of patients in Hanoi and Ho
Chi Minh City (8). However, the Vietnamese study includ-
ed 563 samples from the late 1990s, whereas most
Vietnamese-born immigrants arrived in Denmark during
the early 1980s (19). This finding could indicate that
Beijing strains have been emerging in Vietnam only since
the early 1980s, which would fit with the higher preva-
lence of Beijing strains in persons of younger ages
observed in the Vietnamese study. Regarding strains from
patients born in Eastern Europe, none of the 174 patients
had Beijing strains, compared with reports of 22% to 71%
(4,20–22). However, the strains analyzed most were from
patients from the former Yugoslavia, where the prevalence
of Beijing strains is unknown. These patients arrived in
Denmark during the 1990s. Our data suggest that the
prevalence of Beijing strains was very low in this area, at
least at that time. Few reports from Africa are available
(23–26). In the present study, 17 (1.7%) of the 985
Somalia-born patients, nearly all of whom arrived in
Denmark during the 1990s (18), had Beijing strains.
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Table 2. Proportion of patients with drug-resistant strains 
% Drug resistant (no. of patients with drug resistance)
a   
N  Any drug  Isoniazid  Rifampicin  Streptomycin  Pyrazinamide  Ethambutol  MDR
b 
Danish                 
Beijing  16  12.5 (2)  12.5 (2)  6.3 (1)  12.5 (2)  0.0 (0)  6.3 (1)  6.3 (1) 
Other  1,623  10.2 (165)  3.1 (50)  0.12 (2)  3.6 (58)  5.5 (89)  0.0 (0)  0.0 (0) 
p    0.7  0.09  0.03  0.1  1.0  0.01  0.01 
Immigrants                 
Beijing  78  20.5 (16)  9.0 (7)  0 (0)  16.7 (13)  1.3 (1)  1.3 (1)  0.0 (0) 
Other  2,086  17.2 (359)  7.5 (157)  0.72 (15)  13.6 (284)  1.3 (27)  0.96 (20)  0.58 (12) 
p    0.4  0.7  1.0  0.4  1.0  0.5  1.0 
Overall                 
Beijing  94  19.2 (18)  9.6 (9)  1.1 (1)  16.0 (15)  1.1 (1)  2.1 (2)  1.1 (1) 
Other  3,709  14.1 (524)  5.6 (207)  0.46 (17)  9.2 (342)  3.1 (116)  0.54 (20)  0.32 (12) 
p    0.2  0.1  0.4  0.05  0.5  0.1  0.3 
aDrug resistance data missing for 41 persons. 
bMDR, multidrug resistant. Among the remaining 126 patients, who were born in 24
other African countries, three additional Beijing strains
were retrieved, from patients born in Zimbabwe, Kenya,
and Angola. Beijing strains seem to be rare on the African
continent, but local studies are needed. Immigrants are not
a random sample, and some may have acquired tuberculo-
sis en route.
This is one of the largest samples of strains of M. tuber-
culosis searched for Beijing strains. Although highly rep-
resentative for the Danish population in the 1990s, and
partly for the Danish-born population in the 1960s, the
IS6110 RFLP patterns found in the strains from the for-
eign-born patients may not be an accurate reflection of the
distribution of patterns in their country of origin. Also,
identified patterns are a mixture of “recent” M. tuberculo-
sis transmission and reactivation of latent infections and
thus also represent patterns circulating decades ago
(16,17). 
The low prevalence we found contrasts with some
reports, but limited information is available from most
areas of the world, making definite conclusions about the
extent of spread of Beijing strains and their associations
with drug resistance premature (4). Studies in which
Beijing strains have been looked for but not found may not
have been published. Recently two studies from Delhi and
Bombay, India, reported very few Beijing family strains
(27,28). Similarly, both in this study and in a previous
study, the prevalence of Beijing strains in the Phillippines
was found to be very low, 0% and 2%, respectively (29).
These findings indicate that even in Asia prevalence may
show great variation. More unbiased studies, even those
that report negative findings, are needed. However, the
body of typing data is increasing, thereby disclosing a
growing part of the true tuberculosis picture.
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